Acumen Hypotension Prediction Index (HPI) Feature Software vs FEops HEARTguide

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

Acumen Hypotension Prediction Index (HPI) Feature Software

by Edwards Lifesciences

FEops HEARTguide

by FEops

AI Verdict

These tools are adjacent rather than direct competitors, as they address different phases of patient care within cardiology. Acumen HPI focuses on real-time predictive monitoring and management of hypotension during acute care, aiding clinicians in proactive hemodynamic management. In contrast, FEops HEARTguide is designed for pre-operative planning of structural heart procedures, using predictive simulations to optimize device sizing and positioning.

Choose Acumen Hypotension Prediction Index (HPI) Feature Software if…

Choose Acumen HPI if your primary concern is real-time, proactive management of hemodynamic instability in critically ill patients. This tool is ideal for settings like the OR or ICU where early detection of impending hypotension, up to 15 minutes in advance, can guide timely interventions and improve patient outcomes by reducing the incidence and severity of hypotensive events.

View Acumen Hypotension Prediction Index (HPI) Feature Software →

Choose FEops HEARTguide if…

Choose FEops HEARTguide if you require advanced pre-procedural planning and optimization for structural heart interventions. This cloud-based platform is best suited for cardiologists and cardiothoracic surgeons who need patient-specific predictive simulations and precise anatomical measurements to optimize device sizing and positioning before a procedure, thereby enhancing procedural success and patient safety.

View FEops HEARTguide →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	Acumen Hypotension Prediction Index (HPI) Feature Software	FEops HEARTguide
Deployment	Unknown	Cloud Based platform
FDA Status	Cleared AI-estimated	Cleared AI-estimated
HIPAA	Yes AI-estimated	Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Tie

Tool A is integrated into an existing monitoring platform (HemoSphere), suggesting a streamlined workflow for real-time use. Tool B is cloud-based with 'anytime, anywhere access' and interactive 2D/3D viewers, offering flexibility and advanced visualization for pre-operative planning. Both appear well-designed for their specific applications, making a definitive winner difficult without direct user feedback.

Clinical Value

Acumen Hypotension Prediction Index (HPI) Feature Software

Tool A explicitly states a 'demonstrated reduction in incidence, duration, and severity of intraoperative hypotension,' which is a strong, quantifiable claim of direct clinical impact. While Tool B aims to optimize procedures for improved patient outcomes, Tool A's description provides a more specific and validated outcome.

Pricing & Value

Tie

Both tools list their pricing as 'contact vendor' or 'contact for pricing,' with no publicly available details. Without any transparent pricing information, it is impossible to compare their value propositions.

Enterprise Readiness

Acumen Hypotension Prediction Index (HPI) Feature Software

Tool A is offered by Edwards Lifesciences, a large and established medical device company, and is integrated into their HemoSphere advanced monitoring platform. This suggests robust enterprise support, existing infrastructure integration, and a proven track record in the healthcare market, giving it an edge in readiness for large-scale deployment. Tool B, while HIPAA and FDA compliant and cloud-based, comes from a smaller, specialized company.

Innovation

Tie

Tool A is described as 'first-of-its-kind technology' using machine learning for predictive hypotension, a significant advancement in proactive hemodynamic management. Tool B leverages 'AI and digital twin platform' for patient-specific replicas and predictive simulations in structural heart procedures, which is also a highly innovative application of cutting-edge technology. Both represent substantial innovation in their respective fields.

Support & Docs

Acumen Hypotension Prediction Index (HPI) Feature Software

While specific details on support and documentation are not provided for either tool, Tool A is offered by Edwards Lifesciences, a major global medical technology company. Based on general industry practice, larger companies typically have more extensive, formalized support structures, training programs, and comprehensive documentation compared to smaller, specialized firms like FEops NV.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	Acumen Hypotension Prediction Index (HPI) Feature Software	FEops HEARTguide
Name	Acumen Hypotension Prediction Index (HPI) Feature Software	FEops HEARTguide
Company	Edwards Lifesciences	FEops NV
Description	Edwards Lifesciences' Acumen Hypotension Prediction Index (HPI) software is a predictive monitoring tool that uses machine learning to detect and alert clinicians to the likelihood of a hypotensive event before it occurs, aiding in proactive hemodynamic management and improving patient outcomes.	FEops HEARTguideu2122 is a cloud-based AI and digital twin platform for structural heart procedure planning, providing predictive simulations and anatomical measurements to optimize device sizing and positioning for improved patient outcomes.
Key Features	Hypotension Prediction Index (HPI) parameter (0-100 score); Smart Alerts and Smart Trend screen for impending hypotensive events; Relationship View screen providing insights into preload, afterload, and contractility; Machine learning algorithms for predictive analysis of blood pressure waveforms; Predicts hypotension up to 15 minutes before an event; Demonstrated reduction in incidence, duration, and severity of intraoperative hypotension; Compatibility with both invasive (arterial line) and non-invasive (Acumen IQ cuff) monitoring; Adjustable Mean Arterial Pressure (MAP) target for hypotension definition.	Predictive simulation technology; AI-based anatomical measurements; Digital twin technology for patient-specific replicas; Cloud-based platform with anytime, anywhere access; DICOM interface for CT scan upload; Semi-automatic identification and measurement of anatomical landmarks; Interactive 2D and 3D viewer; Evaluation of device sizing and positioning pre-operatively.
Categories	Cardiology AI, Triage & ER/ICU AI	Cardiology AI, Surgical AI
Specialties	Anesthesiology, Critical Care, Emergency Medicine	Cardiology, Cardiothoracic Surgery

Videos

Demos, reviews, and walkthroughs featuring Acumen Hypotension Prediction Index (HPI) Feature Software and FEops HEARTguide.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What are the primary clinical applications of Acumen HPI Feature Software versus FEops HEARTguide?

Acumen HPI Feature Software is designed for predictive monitoring to detect and alert clinicians to the likelihood of a hypotensive event before it occurs, aiding in proactive hemodynamic management. In contrast, FEops HEARTguide is a cloud-based AI and digital twin platform for structural heart procedure planning, providing predictive simulations and anatomical measurements to optimize device sizing and positioning pre-operatively.

How do the underlying technologies and data inputs differ between these two tools?

Acumen HPI software utilizes machine learning algorithms to analyze blood pressure waveforms, providing a Hypotension Prediction Index (HPI) parameter and insights into preload, afterload, and contractility. FEops HEARTguide employs cloud-based AI and digital twin technology to perform predictive simulations and anatomical measurements, primarily using DICOM interface for CT scan uploads.

Which medical specialties are these tools intended to support?

Acumen HPI Feature Software is primarily intended for specialties such as Anesthesiology, Critical Care, and Emergency Medicine. FEops HEARTguide is designed to support Cardiology and Cardiothoracic Surgery.

What specific predictive insights or outputs do these tools provide to clinicians?

Acumen HPI software provides an HPI parameter (0-100 score), Smart Alerts for impending hypotensive events, and a Relationship View screen offering insights into preload, afterload, and contractility. FEops HEARTguide delivers predictive simulation technology, AI-based anatomical measurements, and digital twin technology to evaluate device sizing and positioning pre-operatively.

What is the demonstrated impact on patient outcomes or clinical efficiency for each tool?

Acumen HPI software has demonstrated a reduction in the incidence, duration, and severity of intraoperative hypotension. FEops HEARTguide aims to optimize device sizing and positioning for improved patient outcomes in structural heart procedures through predictive simulations.